Adults 13 to 99, any sex, with Suicide. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Proportion of Patients in the Target Population Who Agree to ParticipatePrimary· Baseline
Recruitment rate was determined based on the proportion of adolescents providing assent and parents or legal guardians providing permission relative to the number of parents or legal guardians approached.
Group
Value
95% CI
All Potential Adolescent Participants Who Were Approached
0.384
Proportion of Patients in the Target Population Excluded Due to Motion Sickness ScreeningPrimary· Baseline
Rate of recruitment related to motion sickness was determined based on the proportion of assented adolescents whose scores were \>/= than 50th percentile on motion sickness questionnaire relative to the number of assented adolescents.
Group
Value
95% CI
All Assented Adolescent Participants
0.021
Proportion of Participants Who Complete All Study ProceduresPrimary· up to 3-months following school re-entry
Proportion of participants who complete all study procedures was determined based on the proportion of adolescents completing study procedures at Baseline, 2-week follow-up, 3-month follow-up, and journals over the two weeks of their return to school relative to the total number of adolescents participating in that condition.
Group
Value
95% CI
Enhanced Control
0
Affect Regulation
0.800
Problem Solving
0.167
Affect Regulation + Problem Solving
0
Cognitive Restructuring
0.400
Affect Regulation + Cognitive Restructuring
0
Cognitive Restructuring + Problem Solving
0.400
Affect Regulation + Cognitive Restructuring + Problem Solving
0.200
Average Number of Hours to Complete Assessments at Each Time PointPrimary· up to 3-months following school re-entry
Time to complete assessments, assessments are expected to last less than 4 hours. Note that the number of participants to start a Period is not equal to the number who completed previous Period for "Affect Regulation + Problem Solving" and "Cognitive Restructuring + Problem Solving" because 1 participant in each condition was withdrawn or withdrew.
Baseline Pre-assessments
Group
Value
95% CI
Enhanced Control
0.603
± 0.182
Affect Regulation
0.847
± 0.197
Problem Solving
0.842
± 0.333
Affect Regulation + Problem Solving
0.762
± 0.219
Cognitive Restructuring
0.900
± 0.365
Affect Regulation + Cognitive Restructuring
0.747
± 0.220
Cognitive Restructuring + Problem Solving
1.079
± 0.414
Affect Regulation + Cognitive Restructuring + Problem Solving
0.780
± 0.177
Baseline Post-assessments
Group
Value
95% CI
Enhanced Control
0.357
± 0.056
Affect Regulation
0.550
± 0.272
Problem Solving
0.608
± 0.431
Affect Regulation + Problem Solving
0.242
± 0.073
Cognitive Restructuring
0.613
± 0.364
Affect Regulation + Cognitive Restructuring
0.667
± 0.426
Cognitive Restructuring + Problem Solving
0.562
± 0.299
Affect Regulation + Cognitive Restructuring + Problem Solving
0.563
± 0.289
2-Week Return to School Follow-Up
Group
Value
95% CI
Enhanced Control
1.242
± 0.365
Affect Regulation
0.621
± 0.138
Problem Solving
1.208
± 0.620
Affect Regulation + Problem Solving
0.761
± 0.281
Cognitive Restructuring
0.933
± 0.094
Affect Regulation + Cognitive Restructuring
1.133
± 0.306
Cognitive Restructuring + Problem Solving
1.342
± 0.884
Affect Regulation + Cognitive Restructuring + Problem Solving
0.644
± 0.287
3-Month Return to School Follow-Up
Group
Value
95% CI
Enhanced Control
.500
± NA
Affect Regulation
.653
± 0.245
Problem Solving
1.044
± 0.474
Affect Regulation + Problem Solving
0.250
± NA
Cognitive Restructuring
0.592
± 0.295
Affect Regulation + Cognitive Restructuring
0.958
± 0.295
Cognitive Restructuring + Problem Solving
1.017
± 0.731
Affect Regulation + Cognitive Restructuring + Problem Solving
0.983
± NA
Average Number of Minutes to Complete Each Intervention SessionPrimary· Baseline
Time to complete intervention sessions, each session is expected to last less than 60 minutes. Average calculated by summing all sessions in each condition and dividing by total number of sessions. Note that the number of participants to start a Period is not equal to the number who completed previous Period for "Affect Regulation + Problem Solving" and "Cognitive Restructuring + Problem Solving" because 1 participant in each condition was withdrawn or withdrew.
Group
Value
95% CI
Affect Regulation
26.864
± 12.241
Problem Solving
26.333
± 12.473
Affect Regulation + Problem Solving
27.500
± 12.103
Cognitive Restructuring
25.938
± 13.188
Affect Regulation + Cognitive Restructuring
37.083
± 15.197
Cognitive Restructuring + Problem Solving
29.714
± 16.838
Affect Regulation + Cognitive Restructuring + Problem Solving
30.522
± 14.145
Percentage of Adolescent Participants in Which Intervention Delivered With Greater Than or Equal to 80% FidelityPrimary· Baseline
Percentage of participants in which adherence to delivery of key components of intervention (i.e., skill lessons or practice sessions) across sessions in each condition was 80% or greater. Adherence was calculated based on the number of key components completed relative to the total number of key components expected to be completed for each participant. Note that the number of participants to start a Period is not equal to the number who completed previous Period for "Affect Regulation + Problem Solving" and "Cognitive Restructuring + Problem Solving" because 1 participant in each condition wa
Group
Value
95% CI
Affect Regulation
100
Problem Solving
100
Affect Regulation + Problem Solving
100
Cognitive Restructuring
100
Affect Regulation + Cognitive Restructuring
100
Cognitive Restructuring + Problem Solving
100
Affect Regulation + Cognitive Restructuring + Problem Solving
100
Percentage of Adolescent Participants With Average Acceptability Scores Less Than or Equal to 2Primary· Baseline
Percent of adolescents with average acceptability score less than or equal to 2 (or "agree") on a five-point scale from 1 (strongly agree) to 5 (strongly disagree). Note that the number of participants to start a Period is not equal to the number who completed previous Period for "Affect Regulation + Problem Solving" and "Cognitive Restructuring + Problem Solving" because 1 participant in each condition was withdrawn or withdrew, and due to missing post-baseline data for "Problem Solving" (1 participant), "Cognitive Restructuring" (1 participant), "Affect Regulation + Cognitive Restructuring"
Group
Value
95% CI
Affect Regulation
60
Problem Solving
60
Affect Regulation + Problem Solving
100
Cognitive Restructuring
75
Affect Regulation + Cognitive Restructuring
50
Cognitive Restructuring + Problem Solving
100
Affect Regulation + Cognitive Restructuring + Problem Solving
100
Percentage of Hospital Professional Participants With Average Acceptability Scores Less Than or Equal to 2Primary· Baseline
Percent of hospital professionals with average acceptability score less than or equal to 2 (or "agree") on a five-point scale from 1 (strongly agree) to 5 (strongly disagree). Note that the number of participants to start a Period is not equal to the number who completed previous Period for Hospital Professionals because 7 professionals consented into the study, but only 4 delivered the intervention to a patient following consent.
Group
Value
95% CI
Hospital Professionals
25
Adolescents' Perceptions of AcceptabilityPrimary· Baseline
Qualitative feedback provided by adolescents receiving the intervention in the Optimization Trial about acceptability of the intervention. Note that the number of participants to start a Period is not equal to the number who completed previous Period for "Affect Regulation + Problem Solving" and "Cognitive Restructuring + Problem Solving" because 1 participant in each condition was withdrawn or withdrew, and due to missing post-baseline data for "Cognitive Restructuring + Problem Solving" (1 participant).
Endorsed Part or All of the Intervention
Group
Value
95% CI
Affect Regulation
5
Problem Solving
6
Affect Regulation + Problem Solving
4
Cognitive Restructuring
5
Affect Regulation + Cognitive Restructuring
4
Cognitive Restructuring + Problem Solving
4
Affect Regulation + Cognitive Restructuring + Problem Solving
5
Identified Aspects that Could Be Improved
Group
Value
95% CI
Affect Regulation
5
Problem Solving
6
Affect Regulation + Problem Solving
4
Cognitive Restructuring
5
Affect Regulation + Cognitive Restructuring
4
Cognitive Restructuring + Problem Solving
4
Affect Regulation + Cognitive Restructuring + Problem Solving
5
Preferred Learning in Traditional Ways or Described Learning in Virtual Reality as Difficult
Group
Value
95% CI
Affect Regulation
1
Problem Solving
0
Affect Regulation + Problem Solving
0
Cognitive Restructuring
0
Affect Regulation + Cognitive Restructuring
0
Cognitive Restructuring + Problem Solving
0
Affect Regulation + Cognitive Restructuring + Problem Solving
1
Identified Preference or Benefit to Learning in Virtual Realty (as Opposed to Traditional Ways)
Group
Value
95% CI
Affect Regulation
0
Problem Solving
3
Affect Regulation + Problem Solving
0
Cognitive Restructuring
1
Affect Regulation + Cognitive Restructuring
3
Cognitive Restructuring + Problem Solving
1
Affect Regulation + Cognitive Restructuring + Problem Solving
1
Hospital Professionals' Perceptions of AcceptabilityPrimary· Baseline
Qualitative feedback provided by Hospital Professionals delivering the intervention to one or more hospitalized adolescents about acceptability of the intervention. Note that the number of participants to start a Period is not equal to the number who completed previous Period for Hospital Professionals because 7 professionals consented into the study, but only 4 delivered the intervention to a patient following consent.
Endorsed Part or All of the Intervention
Group
Value
95% CI
Hospital Professionals
4
Identified Aspects That Could be Improved
Group
Value
95% CI
Hospital Professionals
4
Adverse events — posted to ClinicalTrials.gov
Time frame: For the Optimization Trial, from signing the informed consent until the 3-Month Return to School Follow-Up or early withdrawal. This time was dependent on the duration of hospital stay and timing of return to school and therefore varied greatly (ranging from 1 day to 405 days). For the Open Trial Period, adverse events for the Adolescent Patients Selected by Hospital Professionals were only monitored during intervention delivery..
Reporting threshold: 5%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
Enhanced Control
Serious: 3/6 (50%)
Deaths: 0/6
Affect Regulation
Serious: 1/5 (20%)
Deaths: 0/5
Problem Solving
Serious: 1/6 (17%)
Deaths: 0/6
Affect Regulation + Problem Solving
Serious: 1/5 (20%)
Deaths: 0/5
Cognitive Restructuring
Serious: 1/5 (20%)
Deaths: 0/5
Affect Regulation + Cognitive Restructuring
Serious: 1/5 (20%)
Deaths: 0/5
Cognitive Restructuring + Problem Solving
Serious: 0/5 (0%)
Deaths: 0/5
Affect Regulation + Cognitive Restructuring + Problem Solving
Serious: 3/5 (60%)
Deaths: 0/5
Hospital Professionals
Serious: 0
Deaths: 0
Adolescent Patients Selected by Hospital Professionals
Serious: 0/5 (0%)
Deaths: 0/5
Serious adverse events (5 terms)
Reaction
System
Enhanced Control
Affect Regulation
Problem Solving
Affect Regulation + Proble…
Cognitive Restructuring
Affect Regulation + Cognit…
Cognitive Restructuring + …
Affect Regulation + Cognit…
Hospital Professionals
Adolescent Patients Select…
Emergency Department Visit for Suicide-Related Risk or Associated Symptoms
Psychiatric disorders
—
—
—
—
—
—
—
—
—
—
Hospitalization for Suicide-Related Risk or Associated Symptoms
Psychiatric disorders
—
—
—
—
—
—
—
—
—
—
Hospitalization for Medical Procedure: GI
Gastrointestinal disorders
—
—
—
—
—
—
—
—
—
—
Hospitalization for Medical Procedure: Skin
Skin and subcutaneous tissue disorders
—
—
—
—
—
—
—
—
—
—
Parent Distress Related to Adolescent Risk Behaviors
This study is developing and refining a novel Virtual Reality (VR) supplement for inpatient treatment: the Practice Experiences for School Reintegration (PrESR) program. The PrESR will provide immersive school experiences for inpatient adolescents (with suicidal-related admissions) to practice skills in real-world settings with the guidance of a trained clinician within the confines of a hospital. This pilot study follows a Multiphase Optimization Strategy (MOST) to conduct a pilot optimization trial of the PrESR to inform the feasibility of training clinicians, the ability to recruit adolescent inpatient participants, and management of experimental conditions. This study is not powered to test hypotheses; however, in addition to assessing feasibility and acceptability, this pilot trial will assess candidate intermediary and outcome measures.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
NCT03835585 — Gun Locks in Firearm Suicide Intervention
· NA
· completed
NCT03655470 — Safety Planning in Juvenile Justice for Suicidal Youth
· NA
· completed
NCT03104504 — A System of Safety (SOS)
· NA
· completed
Other recruiting trials for Suicide
Currently open trials in the same condition.
NCT07404787 — Evaluation of a Telehealth Case Management Intervention to Prevent Suicide Among Soldiers Discharged From Psychiatric Ho
· NA
· recruiting
NCT07214233 — Youth Empowerment and Safety Intervention
· NA
· recruiting
NCT07343258 — Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline
· NA
· recruiting
NCT07523490 — Investigation on Suicide Risk Factors of Patients With Mood Disorders
· recruiting
NCT06571916 — Brief Skills for Safer Living (Brief-SfSL)
· NA
· recruiting
Other University of North Carolina, Chapel Hill trials
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Chapel Hill
Last refreshed: 25 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05934396.